Covance Is Now Labcorp Clinical Trials

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Men and Women, Age 40-65

8472-370 Part 2 Part 2

Back To Current Studies

Men and Women, Age 40-65

Study Number

8472-370 Part 2

Group

Part 2

Gender

both

Age

18 - 64

Location

Dallas, Texas

Compensation

$15,792

Study Dates

Mar. 15 - May 31, 2022

Additional Information

The purpose of Cohort 2 is to evaluate the effect of esomeprazole on the study drug when administered in tablet form, and with or without food. Esomeprazole is a medication used to treat conditions where there is too much acid in the stomach. The safety and tolerability (side effects) of the study drug will also be evaluated.  

Labcorp Dallas, TX is recruiting for:

- Healthy non-smoking men and women of non-childbearing potential, Non-Smoking, age 40-65

- Body Mass Index between 18-32

- Study involves 1 stay for 10 overnights and 2 stays for 15 overnights each and 8 follow-up visits

- Compensation up to $15,792 may be provided for time and travel

Details

Check-In: Mar 15
Check-Out: Mar 25
OPV: Mar 30
OPV: Apr 3
Check-In: Apr 6
Check-Out: Apr 21
OPV: Apr 26
OPV: Apr 30
Check-In: May 4
Check-Out: May 19
OPV: May 24
OPV: May 28
OPV: May 31

Calculate Your BMI!

Your Height:
ft / in
Your Weight:
lbs
Select Measurement System:

Your BMI: result